WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
$12.56
arrow_upward
+0.48%(+0.060) 1 دن
16 اکتوبر, 4:00:00 PM GMT -4 · USD
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoWXXWY کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
$12.29
اعلی
$12.56
کم
$12.20
مارکیٹ کی سرمایہ کاری
1.98 کھرب
اوسط والیوم
61.89 ہزار
والیوم
1.11 لاکھ
52 ہفتے میں اعلی
$14.80
52 ہفتے کا کم
$7.30
بی ٹا
0.01
بقایہ شیئرز
2.06 ارب
ملازمین کی تعداد
15 ہزار
کھولیں
$12.29
اعلی
$12.56
کم
$12.20
مارکیٹ کی سرمایہ کاری
1.98 کھرب
اوسط والیوم
61.89 ہزار
والیوم
1.11 لاکھ
52 ہفتے میں اعلی
$14.80
52 ہفتے کا کم
$7.30
بی ٹا
0.01
بقایہ شیئرز
2.06 ارب
ملازمین کی تعداد
15 ہزار
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
mykxlg.com
·
1 گھنٹہ پہلے
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
The Fintech Times
·
16 منٹ پہلے
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
·
1 گھنٹہ پہلے
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
·
4 گھنٹے پہلے
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
پروفائل
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics Cayman ADR کے بارے میں